Overview

A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)

Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The Global objective of this Basket of Basket study is to evaluate the antitumor activity of each matched therapies that will be evaluated through the study in small molecularly selected populations. The objective of module 1 will be to determine the overall response rate by RECIST 1.1 of atezolizumab in several arms. Subjects will be separated into arms depending on the mutations of their tumour. All patients in genomically selected populations will receive atezolizumab 1200 mg IV every 3 weeks
Phase:
Phase 2
Details
Lead Sponsor:
Vall d'Hebron Institute of Oncology
Collaborators:
IQVIA
Iqvia Pty Ltd
Roche Pharma AG
Treatments:
Antibodies, Monoclonal
Atezolizumab